TrianglePUBLICATIONS · 35576508
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2022 Sep 1
- First author
- Provencio M
This record carries publication-notice metadata. Review the notices below before relying on it.
Publication notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2022 Nov 10;40(32):3785. doi: 10.1200/JCO.22.02137.
- note
- Source null
- related pmid
- 36343382
- relationship
- Erratum in
Authors and identifiers
- name
- Provencio M
- type
- Author
- name
- Serna-Blasco R
- type
- Author
- name
- Nadal E
- type
- Author
- name
- Insa A
- type
- Author
- name
- García-Campelo MR
- type
- Author
- name
- Casal Rubio J
- type
- Author
- name
- Dómine M
- type
- Author
- name
- Majem M
- type
- Author
- name
- Rodríguez-Abreu D
- type
- Author
- name
- Martínez-Martí A
- type
- Author
- name
- De Castro Carpeño J
- type
- Author
- name
- Cobo M
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Provencio M
- type
- Author
- name
- Serna-Blasco R
- type
- Author
- name
- Nadal E
- type
- Author
- name
- Insa A
- type
- Author
- name
- García-Campelo MR
- type
- Author
- name
- Casal Rubio J
- type
- Author
- name
- Dómine M
- type
- Author
- name
- Majem M
- type
- Author
- name
- Rodríguez-Abreu D
- type
- Author
- name
- Martínez-Martí A
- type
- Author
- name
- De Castro Carpeño J
- type
- Author
- name
- Cobo M
- type
- Author
- bibliography ids
- nci-bib-bca57e57e37686934cc9f292
- book metadata
- content sha256
- 8cdf80904475b7176e4b94b00df91dcce4dabc813e37ba3c357b292b431e6e26
- document type
- citation
- dois
- 10.1200/JCO.21.02660
- electronic publication date
- display
- 2022 May 16
- precision
- day
- year
- 2022
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:35576508
- immutable id
- pubmed:35576508@8cdf80904475b7176e4b94b00df91dcce4dabc813e37ba3c357b292b431e6e26
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 25
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 2924-2933
- volume
- 40
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- true
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2022 Nov 10;40(32):3785. doi: 10.1200/JCO.22.02137.
- note
- Source null
- related pmid
- 36343382
- relationship
- Erratum in
- outcomes validated
- false
- pmid
- 35576508
- provenance
- batch id
- 9d150d55960e0c12aada
- provider
- NCBI PubMed ESummary
- record sha256
- e4ed1ba0f12ceb043dbbf1968d4a8eef1f4712ce91607fbc76a45847dc1cbdc6
- response sha256
- 2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
- retrieved at
- 2026-09-09T23:48:09.820498+00:00
- publication date
- display
- 2022 Sep 1
- precision
- day
- year
- 2022
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).
Preserved source evidence · Not medical advice